Grifols initiates study comparing SC and IV Alpha1-PI in Alpha-1 Antitrypsin Deficiency
Grifols Therapeutics LLC is conducting a non-inferiority study comparing weekly subcutaneous Alpha1-PI to standard intravenous dosing in adults with Alpha-1 Antitrypsin Deficiency.